CJC-1295 without DAC

CJC-1295 without DAC is often equated in the literature with Modified GRF(1-29), a shorter-acting GHRH analog lacking the Drug Affinity Complex. Researchers investigate its capacity for transient activation of the GHRH receptor, pulsatile growth hormone release, and dynamic interactions within the GH/IGF-1 axis. Due to the absence of the DAC conjugation, the research focus differs remarkably from its long-acting counterpart, pivoting entirely toward short-duration stimulation models. The literature surrounding GHRH(1-29) analogs demonstrates their capability to briefly stimulate the pituitary gland. This compound serves primarily as a pharmacological research agent in models exploring episodic endocrine regulation.